Tokyo, Japan, Mar 14, 2008 - (JCN Newswire) - Eisai Co., Ltd. (President and CEO: Haruo Naito)announced today that the company submitted an application for a new oral jelly formulation of Aricept(R) (donepezil hydrochloride) in Japan. If approved, it will
